Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 13
Encontrada(s) 1 página(s)

RUC. Repositorio da Universidade da Coruña
Publication Artículo científico (JournalArticle)

Characterizing the Invasive Tumor Front of Aggressive Uterine Adenocarcinoma and Leiomyosarcoma

  • Sanegre, Sabina
  • Eritja, Núria
  • Andrea, Carlos de
  • Díaz-Martín, Juan
  • Díaz-Lagares, Ángel
  • Jácome, M. A.
  • Salguero Aranda, Carmen
  • García-Ros, David
  • Davidson, Ben
  • López-López, Rafael
  • Melero, Ignacio
  • Navarro, Samuel
  • Ramón y Cajal, Santiago
  • Alava, Enrique de
  • Matias-Guiu, Xavier
  • Noguera, Rosa
[Abstract] The invasive tumor front (the tumor–host interface) is vitally important in malignant cell progression and metastasis. Tumor cell interactions with resident and infiltrating host cells and with the surrounding extracellular matrix and secreted factors ultimately determine the fate of the tumor. Herein we focus on the invasive tumor front, making an in-depth characterization of reticular fiber scaffolding, infiltrating immune cells, gene expression, and epigenetic profiles of classified aggressive primary uterine adenocarcinomas (24 patients) and leiomyosarcomas (11 patients). Sections of formalin-fixed samples before and after microdissection were scanned and studied. Reticular fiber architecture and immune cell infiltration were analyzed by automatized algorithms in colocalized regions of interest. Despite morphometric resemblance between reticular fibers and high presence of macrophages, we found some variance in other immune cell populations and distinctive gene expression and cell adhesion-related methylation signatures. Although no evident overall differences in immune response were detected at the gene expression and methylation level, impaired antimicrobial humoral response might be involved in uterine leiomyosarcoma spread. Similarities found at the invasive tumor front of uterine adenocarcinomas and leiomyosarcomas could facilitate the use of common biomarkers and therapies. Furthermore, molecular and architectural characterization of the invasive front of uterine malignancies may provide additional prognostic information beyond established prognostic factors., This research was supported by grants from the ISCIII and ERDF (PI17/01558 and PI20/01107), by the CIBERONC (contracts CB16/12/00484, CB16/12/0328, CB16/12/00363, CB16/12/00364, CB16/12/00481, and CB16/12/00231) and Grupos Coordinados Estables from the Asociación Española Contra el Cáncer (AECC). ÁD-L was funded by a contract “Juan Rodés” from the ISCIII (JR17/00016).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells

  • Fuentes Varela, Pedro
  • Sese Faustino, Marta
  • Guijarro Carrillo, Pedro Jesus
  • Emperador Melero, Marta Isabel
  • Sánchez-Redondo, Sara
  • Peinado, Héctor
  • Hümmer, Stefan
  • Ramon y Cajal Agüeras, Santiago
Molècules de senyalització extracel·lular; Mecanismes de la malaltia; Metàstasi, Moléculas de señalización extracelular; Mecanismos de la enfermedad; Metástasis, Extracellular signalling molecules, Mechanisms of disease; Metastasis, Metastasis, the spread of malignant cells from a primary tumour to distant sites, causes 90% of cancer-related deaths. The integrin ITGB3 has been previously described to play an essential role in breast cancer metastasis, but the precise mechanisms remain undefined. We have now uncovered essential and thus far unknown roles of ITGB3 in vesicle uptake. The functional requirement for ITGB3 derives from its interactions with heparan sulfate proteoglycans (HSPGs) and the process of integrin endocytosis, allowing the capture of extracellular vesicles and their endocytosis-mediated internalization. Key for the function of ITGB3 is the interaction and activation of focal adhesion kinase (FAK), which is required for endocytosis of these vesicles. Thus, ITGB3 has a central role in intracellular communication via extracellular vesicles, proposed to be critical for cancer metastasis., The authors thank Hector Peinado and his laboratory team (Microenvironment & Metastasis Group, Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO)). The authors thank Dr. Manel Bosch for helpful discussion and assistance with confocal microscopy. The authors thank Dr. Anne Spang and Dr Jordi Berenguer for helpful suggestions and discussion on the paper, and Jane Marshall for language review and editing support. This work was supported by Fondo de Investigaciones Sanitarias (PI14/01320), Redes Temáticas de Investigación Cooperativa en Salud (RD12/0036/0057) and CIBERONC (CB16/12/00363). SRC acknowledges support from the Generalitat de Catalunya (2014 SGR 1131). The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech) and it is a member of the ProteoRed PRB3 consortium which is supported by grant PT17/0019 of the PE I + D + i 2013-2016 from the Instituto de Salud Carlos III (ISCIII) and ERDF.
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

The Novel KIF1A Missense Variant (R169T) Strongly Reduces Microtubule Stimulated ATPase Activity and Is Associated With NESCAV Syndrome

  • Aguilera, Cinthia
  • Hümmer, Stefan
  • Masanas Jimenez, Marc
  • Gabau, Elisabeth
  • Guitart, Miriam
  • Jeyaprakash, A. Arockia
  • Segura Ginard, Miguel
  • Ruiz, Anna
  • Santamaria Margalef, Anna
Síndrome de NESCAV; Kinesina; Microtúbul, Síndrome de NESCAV; Kinesina; Microtubulo, NESCAV syndrome; Kinesin; Microtubule, KIF1A is a microtubule-dependent motor protein responsible for fast anterograde transport of synaptic vesicle precursors in neurons. Pathogenic variants in KIF1A have been associated with a wide spectrum of neurological disorders. Here, we report a patient presenting a severe neurodevelopmental disorder carrying a novel de novo missense variant p.Arg169Thr (R169T) in the KIF1A motor domain. The clinical features present in our patient match with those reported for NESCAV syndrome including severe developmental delay, spastic paraparesis, motor sensory neuropathy, bilateral optic nerve atrophy, progressive cerebellar atrophy, epilepsy, ataxia, and hypotonia. Here, we demonstrate that the microtubule-stimulated ATPase activity of the KIF1A is strongly reduced in the motor domain of the R169T variant. Supporting this, in silico structural modeling suggests that this variant impairs the interaction of the KIF1A motor domain with microtubules. The characterization of the molecular effect of the R169T variant on the KIF1A protein together with the presence of the typical clinical features indicates its causal pathogenic effect., This work was supported by the Instituto de Salud Carlos III (Grant No. PI16/01411 to MG and Grant No. CPII18/00027 to AS), the Asociación Española de Síndrome de Angelman, Institut d’investigació i innovació Parc Taulí I3PT (CIR2018/021), the Ministerio de Educación, Cultura y Deporte (Grant No. FPU16/01099 to MM), the Asociación Española Contra el Cáncer (Grant No. LABAE18009SEGU to MS), and the Centro de Investigación Biomédica en Red Cancer - CIBERONC (Grant No. CB16/12/00363 to SH). Finally, AJ was supported by the Wellcome Trust though a Senior Research Fellowship (202811).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Clinical implications of intratumor heterogeneity: challenges and opportunities

  • Ramon y Cajal Agüeras, Santiago
  • Sese Faustino, Marta
  • Capdevila Castillo, Clàudia
  • Aasen, Trond
  • Mattos Arruda, Leticia de
  • Diaz-Cano, Salvador J.
  • Hernandez Losa, Javier
  • Castellví Vives, Josep
Heterogeneidad intratumoral; Inteligencia artificial; Terapias antitumorales, Heterogeneïtat intratumoral; Intel·ligència artificial; Teràpies antitumorals, Intratumor heterogeneity; Artificial intelligence; Antitumor therapeutics, In this review, we highlight the role of intratumoral heterogeneity, focusing on the clinical and biological ramifications this phenomenon poses. Intratumoral heterogeneity arises through complex genetic, epigenetic, and protein modifications that drive phenotypic selection in response to environmental pressures. Functionally, heterogeneity provides tumors with significant adaptability. This ranges from mutual beneficial cooperation between cells, which nurture features such as growth and metastasis, to the narrow escape and survival of clonal cell populations that have adapted to thrive under specific conditions such as hypoxia or chemotherapy. These dynamic intercellular interplays are guided by a Darwinian selection landscape between clonal tumor cell populations and the tumor microenvironment. Understanding the involved drivers and functional consequences of such tumor heterogeneity is challenging but also promises to provide novel insight needed to confront the problem of therapeutic resistance in tumors., SRYC received support from Fondo de Investigaciones Sanitarias (PI14/01320 and PI17/02247), Redes Temáticas de Investigación Cooperativa en Salud (RD12/0036/0057), CIBERONC (CB16/12/00363), and Generalitat de Catalunya (AGAUR, 2017 SGR 1799 and 2014 SGR 1131). TA received support from Instituto de Salud Carlos III (grants PI16/00772 and CPII16/00042), co-financed by the European Regional Development Fund (ERDF).
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor

  • Bou-Petit, Elisabeth
  • Hummer, Stefan
  • Alarcon, Helena
  • Slobodnyuk, Konstantin
  • Cano Galietero, Marta
  • Fuentes Varela, Pedro
  • Guijarro Carrillo, Pedro Jesus
  • Muñoz Guijarro, Maria José
  • Suarez Cabrera, Leticia
  • Ramon y Cajal Agüeras, Santiago
  • Santamaria Margalef, Anna
Inhibidor de MNK1; Oncología, Inhibidor de MNK1; Oncologia, MNK1 inhibitor; Oncology, Targeting the kinases MNK1 and MNK2 has emerged as a valuable strategy in oncology. However, most of the advanced inhibitors are acting in an adenosine triphosphate (ATP)-competitive mode, precluding the evaluation of different binding modes in preclinical settings. Using rational design, we identified and validated the 4,6-diaryl-pyrazolo[3,4-b]pyridin-3-amine scaffold as the core for MNK inhibitors. Signaling pathway analysis confirmed a direct effect of the hit compound EB1 on MNKs, and in line with the reported function of these kinases, EB1 only affects the growth of tumor but not normal cells. Molecular modeling revealed the binding of EB1 to the inactive conformation of MNK1 and the interaction with the specific DFD motif. This novel mode of action appears to be superior to the ATP-competitive inhibitors, which render the protein in a pseudo-active state. Overcoming this paradoxical activation of MNKs by EB1 represents therefore a promising starting point for the development of a novel generation of MNK inhibitors., This work was supported by the Instituto de Salud Carlos III (PI17/02247), (PI20/01687), and CIBERONC (CB16/12/00363). S.R.y.C. acknowledges support from the Generalitat de Catalunya (2017-9015-385045). E. Bou-Petit thanks the Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement de la Generalitat de Catalunya (2017 FI_B2 00139) and the European Social Funds for her predoctoral fellowship.
Dipòsit Digital de Documents de la UAB
Publication Artículo de revisión (ReviewArticle)

Clinical implications of intratumor heterogeneity, challenges and opportunities

  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
  • Sesé, Marta|||0000-0003-1473-4833
  • Capdevila, Claudia
  • Aasen, Trond|||0000-0003-0763-2695
  • De Mattos-Arruda, Leticia|||0000-0002-4992-3645
  • Diaz-Cano, Salvador J.
  • Hernandez-Losa, Javier|||0000-0003-1526-3201
  • Castellvi, Josep|||0000-0001-5745-9996
In this review, we highlight the role of intratumoral heterogeneity, focusing on the clinical and biological ramifications this phenomenon poses. Intratumoral heterogeneity arises through complex genetic, epigenetic, and protein modifications that drive phenotypic selection in response to environmental pressures. Functionally, heterogeneity provides tumors with significant adaptability. This ranges from mutual beneficial cooperation between cells, which nurture features such as growth and metastasis, to the narrow escape and survival of clonal cell populations that have adapted to thrive under specific conditions such as hypoxia or chemotherapy. These dynamic intercellular interplays are guided by a Darwinian selection landscape between clonal tumor cell populations and the tumor microenvironment. Understanding the involved drivers and functional consequences of such tumor heterogeneity is challenging but also promises to provide novel insight needed to confront the problem of therapeutic resistance in tumors.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells

  • Fuentes Varela, Pedro|||0000-0001-8471-0197
  • Sesé, Marta|||0000-0003-1473-4833
  • Guijarro, Pedro J.
  • Emperador, Marta|||0000-0002-8538-4319
  • Sánchez-Redondo, Sara
  • Peinado, Héctor|||0000-0002-4256-3413
  • Hümmer, Stefan|||0000-0002-8184-3872
  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
Metastasis, the spread of malignant cells from a primary tumour to distant sites, causes 90% of cancer-related deaths. The integrin ITGB3 has been previously described to play an essential role in breast cancer metastasis, but the precise mechanisms remain undefined. We have now uncovered essential and thus far unknown roles of ITGB3 in vesicle uptake. The functional requirement for ITGB3 derives from its interactions with heparan sulfate proteoglycans (HSPGs) and the process of integrin endocytosis, allowing the capture of extracellular vesicles and their endocytosis-mediated internalization. Key for the function of ITGB3 is the interaction and activation of focal adhesion kinase (FAK), which is required for endocytosis of these vesicles. Thus, ITGB3 has a central role in intracellular communication via extracellular vesicles, proposed to be critical for cancer metastasis. The integrin ITGB3 has been described to play an essential role in breast cancer metastasis, but the precise mechanisms remain undefined. Here the authors describe thus far unknown roles of ITGB3 in the uptake of extracellular vesicles, required for colony growth of breast cancer cells
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

The Novel KIF1A Missense Variant (R169T) Strongly Reduces Microtubule Stimulated ATPase Activity and Is Associated With NESCAV Syndrome

  • Aguilera, Cinthia|||0000-0002-0363-8590
  • Hümmer, Stefan|||0000-0002-8184-3872
  • Masanas, Marc|||0000-0002-2249-8554
  • Gabau, Elisabeth|||0000-0001-8120-7393
  • Guitart, Maria|||0000-0003-2957-7404
  • Jeyaprakash, A. Arockia
  • Segura, Miguel F.|||0000-0003-0916-3618
  • Santamaría Margalef, Anna|||0000-0001-6726-8990
  • Ruiz, Anna|||0000-0001-7314-5962
KIF1A is a microtubule-dependent motor protein responsible for fast anterograde transport of synaptic vesicle precursors in neurons. Pathogenic variants in KIF1A have been associated with a wide spectrum of neurological disorders. Here, we report a patient presenting a severe neurodevelopmental disorder carrying a novel de novo missense variant p.Arg169Thr (R169T) in the KIF1A motor domain. The clinical features present in our patient match with those reported for NESCAV syndrome including severe developmental delay, spastic paraparesis, motor sensory neuropathy, bilateral optic nerve atrophy, progressive cerebellar atrophy, epilepsy, ataxia, and hypotonia. Here, we demonstrate that the microtubule-stimulated ATPase activity of the KIF1A is strongly reduced in the motor domain of the R169T variant. Supporting this, in silico structural modeling suggests that this variant impairs the interaction of the KIF1A motor domain with microtubules. The characterization of the molecular effect of the R169T variant on the KIF1A protein together with the presence of the typical clinical features indicates its causal pathogenic effect.
Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Integrating digital pathology with transcriptomic and epigenomic tools for predicting metastatic uterine tumor aggressiveness

  • Sonzini, Giorgia
  • Granados-Aparici, Sofia
  • Sanegre, Sabina
  • Diaz-Lagares, Angel|||0000-0002-9114-9227
  • Diaz-Martin, Juan
  • de Andrea, Carlos
  • Eritja, Núria
  • Bao Caamano, Aida
  • Costa-Fraga, Nicolás|||0000-0002-0869-8509
  • García-Ros, David
  • Salguero-Aranda, Carmen
  • Davidson, Ben
  • López-López, Rafael|||0000-0002-2240-6277
  • Melero, Ignacio|||0000-0002-1360-348X
  • Navarro, Samuel
  • Ramón y Cajal, Santiago|||0000-0002-3867-1390
  • De Álava, Enrique|||0000-0001-8400-046X
  • Matías-Guiu, Xavier|||0000-0002-7201-6605
  • Noguera, Rosa
The incidence of new cancer cases is expected to increase significantly in the future, posing a worldwide problem. In this regard, precision oncology and its diagnostic tools are essential for developing personalized cancer treatments. Digital pathology (DP) is a particularly key strategy to study the interactions of tumor cells and the tumor microenvironment (TME), which play a crucial role in tumor initiation, progression and metastasis. The purpose of this study was to integrate data on the digital patterns of reticulin fiber scaffolding and the immune cell infiltrate, transcriptomic and epigenetic profiles in aggressive uterine adenocarcinoma (uADC), uterine leiomyosarcoma (uLMS) and their respective lung metastases, with the aim of obtaining key TME biomarkers that can help improve metastatic prediction and shed light on potential therapeutic targets. Automatized algorithms were used to analyze reticulin fiber architecture and immune infiltration in colocalized regions of interest (ROIs) of 133 invasive tumor front (ITF), 89 tumor niches and 70 target tissues in a total of six paired samples of uADC and nine of uLMS. Microdissected tissue from the ITF was employed for transcriptomic and epigenetic studies in primary and metastatic tumors. Reticulin fiber scaffolding was characterized by a large and loose reticular fiber network in uADC, while dense bundles were found in uLMS. Notably, more similarities between reticulin fibers were observed in paired uLMS then paired uADCs. Transcriptomic and multiplex immunofluorescence-based immune profiling showed a higher abundance of T and B cells in primary tumor and in metastatic uADC than uLMS. Moreover, the epigenetic signature of paired samples in uADCs showed more differences than paired samples in uLMS. Some epigenetic variation was also found between the ITF of metastatic uADC and uLMS. Altogether, our data suggest a correlation between morphological and molecular changes at the ITF and the degree of aggressiveness. The use of DP tools for characterizing reticulin scaffolding and immune cell infiltration at the ITF in paired samples together with information provided by omics analyses in a large cohort will hopefully help validate novel biomarkers of tumor aggressiveness, develop new drugs and improve patient quality of life in a much more efficient way.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

The Novel KIF1A Missense Variant (R169T) Strongly Reduces Microtubule Stimulated ATPase Activity and Is Associated With NESCAV Syndrome

  • Aguilera, Cinthia
  • Hümmer, Stefan
  • Masanas Jimenez, Marc
  • Gabau, Elisabeth
  • Guitart, Miriam
  • Jeyaprakash, A. Arockia
  • Segura Ginard, Miguel
  • Ruiz, Anna
  • Santamaria Margalef, Anna
Síndrome de NESCAV; Kinesina; Microtúbul, Síndrome de NESCAV; Kinesina; Microtubulo, NESCAV syndrome; Kinesin; Microtubule, KIF1A is a microtubule-dependent motor protein responsible for fast anterograde transport of synaptic vesicle precursors in neurons. Pathogenic variants in KIF1A have been associated with a wide spectrum of neurological disorders. Here, we report a patient presenting a severe neurodevelopmental disorder carrying a novel de novo missense variant p.Arg169Thr (R169T) in the KIF1A motor domain. The clinical features present in our patient match with those reported for NESCAV syndrome including severe developmental delay, spastic paraparesis, motor sensory neuropathy, bilateral optic nerve atrophy, progressive cerebellar atrophy, epilepsy, ataxia, and hypotonia. Here, we demonstrate that the microtubule-stimulated ATPase activity of the KIF1A is strongly reduced in the motor domain of the R169T variant. Supporting this, in silico structural modeling suggests that this variant impairs the interaction of the KIF1A motor domain with microtubules. The characterization of the molecular effect of the R169T variant on the KIF1A protein together with the presence of the typical clinical features indicates its causal pathogenic effect., This work was supported by the Instituto de Salud Carlos III (Grant No. PI16/01411 to MG and Grant No. CPII18/00027 to AS), the Asociación Española de Síndrome de Angelman, Institut d’investigació i innovació Parc Taulí I3PT (CIR2018/021), the Ministerio de Educación, Cultura y Deporte (Grant No. FPU16/01099 to MM), the Asociación Española Contra el Cáncer (Grant No. LABAE18009SEGU to MS), and the Centro de Investigación Biomédica en Red Cancer - CIBERONC (Grant No. CB16/12/00363 to SH). Finally, AJ was supported by the Wellcome Trust though a Senior Research Fellowship (202811).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Clinical implications of intratumor heterogeneity: challenges and opportunities

  • Ramon y Cajal Agüeras, Santiago
  • Sese Faustino, Marta
  • Capdevila Castillo, Clàudia
  • Aasen, Trond
  • Mattos Arruda, Leticia de
  • Diaz-Cano, Salvador J.
  • Hernandez Losa, Javier
  • Castellví Vives, Josep
Heterogeneidad intratumoral; Inteligencia artificial; Terapias antitumorales, Heterogeneïtat intratumoral; Intel·ligència artificial; Teràpies antitumorals, Intratumor heterogeneity; Artificial intelligence; Antitumor therapeutics, In this review, we highlight the role of intratumoral heterogeneity, focusing on the clinical and biological ramifications this phenomenon poses. Intratumoral heterogeneity arises through complex genetic, epigenetic, and protein modifications that drive phenotypic selection in response to environmental pressures. Functionally, heterogeneity provides tumors with significant adaptability. This ranges from mutual beneficial cooperation between cells, which nurture features such as growth and metastasis, to the narrow escape and survival of clonal cell populations that have adapted to thrive under specific conditions such as hypoxia or chemotherapy. These dynamic intercellular interplays are guided by a Darwinian selection landscape between clonal tumor cell populations and the tumor microenvironment. Understanding the involved drivers and functional consequences of such tumor heterogeneity is challenging but also promises to provide novel insight needed to confront the problem of therapeutic resistance in tumors., SRYC received support from Fondo de Investigaciones Sanitarias (PI14/01320 and PI17/02247), Redes Temáticas de Investigación Cooperativa en Salud (RD12/0036/0057), CIBERONC (CB16/12/00363), and Generalitat de Catalunya (AGAUR, 2017 SGR 1799 and 2014 SGR 1131). TA received support from Instituto de Salud Carlos III (grants PI16/00772 and CPII16/00042), co-financed by the European Regional Development Fund (ERDF).
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor

  • Bou-Petit, Elisabeth
  • Hummer, Stefan
  • Alarcon, Helena
  • Slobodnyuk, Konstantin
  • Cano Galietero, Marta
  • Fuentes Varela, Pedro
  • Guijarro Carrillo, Pedro Jesus
  • Muñoz Guijarro, Maria José
  • Suarez Cabrera, Leticia
  • Ramon y Cajal Agüeras, Santiago
  • Santamaria Margalef, Anna
Inhibidor de MNK1; Oncología, Inhibidor de MNK1; Oncologia, MNK1 inhibitor; Oncology, Targeting the kinases MNK1 and MNK2 has emerged as a valuable strategy in oncology. However, most of the advanced inhibitors are acting in an adenosine triphosphate (ATP)-competitive mode, precluding the evaluation of different binding modes in preclinical settings. Using rational design, we identified and validated the 4,6-diaryl-pyrazolo[3,4-b]pyridin-3-amine scaffold as the core for MNK inhibitors. Signaling pathway analysis confirmed a direct effect of the hit compound EB1 on MNKs, and in line with the reported function of these kinases, EB1 only affects the growth of tumor but not normal cells. Molecular modeling revealed the binding of EB1 to the inactive conformation of MNK1 and the interaction with the specific DFD motif. This novel mode of action appears to be superior to the ATP-competitive inhibitors, which render the protein in a pseudo-active state. Overcoming this paradoxical activation of MNKs by EB1 represents therefore a promising starting point for the development of a novel generation of MNK inhibitors., This work was supported by the Instituto de Salud Carlos III (PI17/02247), (PI20/01687), and CIBERONC (CB16/12/00363). S.R.y.C. acknowledges support from the Generalitat de Catalunya (2017-9015-385045). E. Bou-Petit thanks the Secretaria d’Universitats i Recerca del Departament d’Economia i Coneixement de la Generalitat de Catalunya (2017 FI_B2 00139) and the European Social Funds for her predoctoral fellowship.
Scientia. Dipòsit d'Informació Digital del Departament de Salut
Publication Artículo científico (JournalArticle)

ITGB3-mediated uptake of small extracellular vesicles facilitates intercellular communication in breast cancer cells

  • Fuentes Varela, Pedro
  • Sese Faustino, Marta
  • Guijarro Carrillo, Pedro Jesus
  • Emperador Melero, Marta Isabel
  • Sánchez-Redondo, Sara
  • Peinado, Héctor
  • Hümmer, Stefan
  • Ramon y Cajal Agüeras, Santiago
Molècules de senyalització extracel·lular; Mecanismes de la malaltia; Metàstasi, Moléculas de señalización extracelular; Mecanismos de la enfermedad; Metástasis, Extracellular signalling molecules, Mechanisms of disease; Metastasis, Metastasis, the spread of malignant cells from a primary tumour to distant sites, causes 90% of cancer-related deaths. The integrin ITGB3 has been previously described to play an essential role in breast cancer metastasis, but the precise mechanisms remain undefined. We have now uncovered essential and thus far unknown roles of ITGB3 in vesicle uptake. The functional requirement for ITGB3 derives from its interactions with heparan sulfate proteoglycans (HSPGs) and the process of integrin endocytosis, allowing the capture of extracellular vesicles and their endocytosis-mediated internalization. Key for the function of ITGB3 is the interaction and activation of focal adhesion kinase (FAK), which is required for endocytosis of these vesicles. Thus, ITGB3 has a central role in intracellular communication via extracellular vesicles, proposed to be critical for cancer metastasis., The authors thank Hector Peinado and his laboratory team (Microenvironment & Metastasis Group, Molecular Oncology Program, Spanish National Cancer Research Centre (CNIO)). The authors thank Dr. Manel Bosch for helpful discussion and assistance with confocal microscopy. The authors thank Dr. Anne Spang and Dr Jordi Berenguer for helpful suggestions and discussion on the paper, and Jane Marshall for language review and editing support. This work was supported by Fondo de Investigaciones Sanitarias (PI14/01320), Redes Temáticas de Investigación Cooperativa en Salud (RD12/0036/0057) and CIBERONC (CB16/12/00363). SRC acknowledges support from the Generalitat de Catalunya (2014 SGR 1131). The CRG/UPF Proteomics Unit is part of the Spanish Infrastructure for Omics Technologies (ICTS OmicsTech) and it is a member of the ProteoRed PRB3 consortium which is supported by grant PT17/0019 of the PE I + D + i 2013-2016 from the Instituto de Salud Carlos III (ISCIII) and ERDF.